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Histopathologically, placenta accreta is now universally defined by a partial or complete absence of decidua basalis, resulting in placental villi being attached to or invading into the scarred myometrium underneath. [2] [3] [4] Placenta accreta is graded according to the depth of villous invasiveness into placenta creta or vera when the villi adhere to the myometrium without invading it, placenta increta when the villi invade the myometrium, and placenta percreta when the villi invade down to or penetrate through the uterine serosa. [2] [3] [4] Abnormal adherence or invasion results in the failure of the placenta to separate normally from the uterine wall at delivery. When unsuspected at the time of delivery, attempts to manually remove a placenta accreta typically provoke massive hemorrhage, leading to high maternal morbidity and mortality.
BACKGROUND: Women with a history of previous cesarean delivery, presenting with a placenta previa, have become the largest group with the highest risk for placenta previa accreta. OBJECTIVE: The objective of the study was to evaluate the accuracy of ultrasound imaging in the prenatal diagnosis of placenta accreta and the impact of the depth of villous invasion on management in women presenting with placenta previa or low-lying placenta and with 1 or more prior cesarean deliveries. STUDY DESIGN AND DATA SOURCES: We searched PubMed, Google Scholar, clinicalTrials.gov, and MEDLINE for studies published between 1982 and November 2016. STUDY ELIGIBILITY CRITERIA: Criteria for the study were cohort studies that provided data on previous mode of delivery, placenta previa, or low-lying placenta on prenatal ultrasound imaging and pregnancy outcome. The initial search identified 171 records, of which 5 retrospective and 9 prospective cohort studies were eligible for inclusion in the quantitative analysis.
STUDY APPRAISAL AND SYNTHESIS METHODS:
The studies were scored on methodological quality using the Quality Assessment of Diagnostic Accuracy Studies tool. RESULTS: The 14 cohort studies included 3889 pregnancies presenting with placenta previa or low-lying placenta and 1 or more prior cesarean deliveries screened for placenta accreta. There were 328 cases of placenta previa accreta (8.4%), of which 298 (90.9%) were diagnosed prenatally by ultrasound. The incidence of placenta previa accreta was 4.1% in women with 1 prior cesarean and 13.3% in women with !2 previous cesarean deliveries. The pooled performance of ultrasound for the antenatal detection of placenta previa accreta was higher in prospective than retrospective studies, with a diagnostic odds ratios of 228.5 (95% confidence interval, 67.2e776.9) and 80.8 (95% confidence interval, 13.0e501.4), respectively. Only 2 studies provided detailed data on the relationship between the depth of villous invasion and the number of previous cesarean deliveries, independently of the depth of the villous invasion. A cesarean hysterectomy was performed in 208 of 232 cases (89.7%) for which detailed data on management were available. Positive correlations were found in the largest prospective studies between the cumulative rates of the more invasive forms of accreta placentation and the sensitivity and specificity of ultrasound imaging but not with diagnostic odds ratio values. We found no data on the ultrasound screening of placenta accreta at the routine midtrimester ultrasound examination from the nonexpert ultrasound units. CONCLUSION: Planning individual management for delivery is possible only with accurate evaluation of prenatal risk of accreta placentation in women presenting with a lowlying placenta/previa and a history of prior cesarean delivery. Ultrasound is highly sensitive and specific in the prenatal diagnosis of accreta placentation when performed by skilled operators. Developing a prenatal screening protocol is now essential to further improve the outcome of this increasingly more common major obstetric complication.
There is increasing evidence that multidisciplinary management of patients with suspected placenta accreta is superior to standard obstetric care. [5] [6] [7] For such care to be organized, the diagnosis must be made prenatally. [8] [9] [10] Recent population studies have shown that accreta placentation remains undiagnosed before delivery in half 11, 12 to two thirds of the cases. 13 Even in series from specialist centers, up to a third of cases of placenta accreta are not diagnosed during pregnancy. 14 The incidence of placenta accreta is directly linked with the increase in cesarean delivery. [13] [14] [15] [16] [17] [18] [19] The main additional factor for the risk of placenta accreta after a previous cesarean delivery is placenta previa. The risks of both placenta previa and placenta accreta in subsequent pregnancies increase with the number of previous cesarean deliveries 13, 16, 20, 21 and is higher in women with a previous classical cesarean delivery. 21 A large multicenter cohort study has noted that for women presenting with placenta previa and prior cesarean delivery, the risk of accreta placentation is 3%, 11%, 40%, 61%, and 67% for first, second, third, fourth, and fifth or more cesarean deliveries, respectively. 17 These risks are independent of other maternal characteristics, such as parity, body mass index, tobacco use, and coexisting hypertension or diabetes. 2, 4, 14, 15, 17 Given these data, the identification at the midtrimester ultrasound examination of an anterior placenta previa or low-lying placenta in a woman with a history of cesarean delivery should prompt a more detailed search for signs of placenta accreta and evaluation of the depth of villous myometrial invasion.
The main objective of this review is to evaluate the accuracy of ultrasound imaging in diagnosing placenta previa accreta in women presenting prenatally with prior cesarean delivery. Cases of placenta accreta following other types of uterine surgeries were excluded from our review and analysis. We have also evaluated the impact of the prenatal diagnosis of placenta previa accreta on pregnancy management and outcome and address the issues in screening for these high-risk cases in the growing number of women with a history of cesarean delivery in the general population.
Material and Methods
Systematic review information sources and search strategy We undertook a PubMed, Google Scholar, clinicalTrials.gov, and MED-LINE search for studies published between the first prenatal ultrasound description of placenta accreta in 1982 by Tabsh et al 22 and Nov. 1, of 2016. The search protocol was designed a priori and registered on PROSPERO (number 42016049990) (http://www.crd.york.ac. uk/PROSPERO).
The search strategy consisted of MeSH headings for placenta accreta, placenta increta, placenta percreta, abnormally invasive placenta, and morbidly adherent placenta, which were combined with terms regarding placenta previa, low-lying placenta, sonography, ultrasound diagnosis, ultrasound screening, prenatal diagnosis, cesarean section, or cesarean delivery. Title, abstracts, and full text were independently assessed by the authors for content, data extraction, and analysis. References of included studies were also reviewed. The search was limited to articles published in English. We contacted the authors for clarification in which 2 Â 2 tables could not be constructed from the published data.
Systematic review eligibility criteria
The primary eligibility criteria were articles that correlated prenatal ultrasound imaging with pregnancy outcome in women with a history of previous cesarean delivery and presenting with a placenta previa or low-lying placenta.
We included retrospective and prospective cohort studies. The index test consisted of at least 1 ultrasound evaluation performed during pregnancy with the specific aim of diagnosing placenta accreta. The reference standard for confirmation of accreta placentation after delivery was histopathological observation of placental villi directly attached to the myometrium or invading the uterine wall or at delivery by direct observation by the operating surgeon.
Systematic review study selection The initial database search provided 166 reports and cross-referencing provided an additional 5 reports, making a total of 171 records after removal of 3 duplicates (Figure 1 ). Of the 171 records screened, 86 did not include data on prenatal ultrasound imaging of placenta accreta and were therefore excluded. After a second selection, case reports and letters with no description of the case were excluded. The full text of 26 articles identified on second selection were read independently and were examined in detail the authors. A further 12 reports in which antenatal ultrasound was performed but the cohort studies did not include data on previous uterine surgery were excluded, leaving 14 reports for the quantitative analysis.
The authors independently assessed inclusion criteria, data extraction, and analysis. The studies were scored on methodological quality using the Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2) using 4 key domains: patient selection, index test, reference standard, and flow and timing. 23 The quality items assessed were study design and the conduct and analysis of all included studies. Each item was scored as high or low or unclear if there was insufficient information to make an accurate judgment on the risk for bias. When there was inconsistency in study selection or quality assessment, we solved it by weighing arguments.
We constructed 2 Â 2 tables, crossclassifying the outcome of the index test against the outcome of the reference standard. Authors were contacted for additional data if it was not possible to create 2 Â 2 tables. Heterogeneity was identified using Cochran's Q test and the I 2 statistic, in which P <.05 and I 2 ! 50% indicate significant heterogeneity as previously described. 24 According to the results of heterogeneity testing, we chose a random statistical model to pool data with 95% confidence interval (CI) on sensitivity, specificity, positive and negative likelihood ratios, and the diagnostic odds ratio (DOR) defined as the ratio of the odds of the test being positive if the Systematic Reviews ajog.org subject has a disease relative to the odds of the test being positive if the subject does not have the disease. Data analysis was performed using the statistical software package Meta-DiSc (http://www. hrc.es/investigacion/metadisc_en.htm) and visualized using a Forest plot.
Clinical study characteristics were subsequently extracted using a predesigned data extraction form including the following: year of publication, number of cases of placenta praevia screened, number of placenta accreta in the study population, gestational age at diagnosis, and histopathological confirmation (primary outcome). In addition, data on outcome were extracted including gestational age at delivery, type of management, and depth of villous invasiveness (secondary outcome).
StatGraphic data analysis and statistical software package (Manugistics, Rockville, MD) was used to calculate relationships between parameters when required. A value of P < .05 was considered significant.
Results

Systematic review report characteristics
The final selection included 5 retrospective 25-29 and 9 prospective [30] [31] [32] [33] [34] [35] [36] [37] [38] cohort studies. The summarized QUADAS-2 assessment is shown in Figure 2 . The reference standard was scored unclear risk of bias in every study because of the following:
1. Histopathology was not available in women not suspected of normal placentation who were correctly diagnosed by ultrasound. 2. It was not generally possible to blind the pathologist to the ultimate diagnosis because hysterectomy is not commonly performed in pregnancy, and invasive placentation is a recognized indication for cesarean hysterectomy.
Systematic review synthesis of results Table 1 displays the primary outcome characteristics of the 14 studies. These cohort studies included 3889 pregnancies presenting with a placenta previa or a low-lying placenta screen for placenta accreta. The largest cohort studies were based in the United States. 25, 27, 29, [30] [31] [32] [33] In total, there were 328 pregnancies (8.4%) complicated by placenta accreta. The incidence of placenta accreta was 14.9% (range, 7.5e29.4%) and 6.4% (range, 0.7e47.2%) in the retrospective and prospective cohort studies, respectively. Five studies included both low-lying and placenta previa in their screening population of women with a previous cesarean delivery. 25, 26, 29, 32, 38 In only one of these studies, 29 the low-lying placenta was described as a placental edge within 2 cm of the cervical os but not covering it. The incidence of placenta accreta was lowest (0.7e8.9%) in those studies in which the authors did separate low-lying placental position from placenta previa. 25, 26, 32, 37 The distribution of the number of previous cesarean deliveries in women presenting with a placenta previa accreta confirmed at delivery was reported by 8 authors. [27] [28] [29] 31, 33, [36] [37] [38] When pooled, these data showed that of 214 placenta previa accreta cases included in these studies, 50 women (23.4%) had a history of 1 previous cesarean delivery and 164 (76.6%) had !2 previous cesarean deliveries. When referred to the total number of women screened in those studies (n ¼ 1233), the incidence of placenta previa accreta was 4.1% in women with 1 previous cesarean delivery and 13 .3% in women with !2 previous cesarean deliveries.
Overall, 298 cases of placenta accreta (90.9%) were diagnosed prenatally by ultrasound and confirmed clinically at delivery and/or by histopathology. The pooled performance of ultrasound for the prenatal diagnosis of placenta previa accreta in the retrospective studies was as QUADAS, Quality Assessment of Diagnostic Accuracy Studies.
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ajog.org Systematic Reviews follows: sensitivity, 88.0% (95% CI, 81.0e93.0); specificity, 90.0% (95% CI, 88.0e93.0), and DOR, 80.8 (95% CI, 13.0e501.4) (Figure 3 ). Positive and negative likelihood ratios were 8.8 and 0.13, respectively. In the prospective studies, the pooled performance was higher, with a sensitivity of 97.0% (95% CI, 93.0e99.0); specificity of 97.0% (95% CI, 97.0e98.0), and DOR of 228.5 (95% CI, 67.2e776.9) (Figure 4 ). Positive and negative likelihood ratios were 32 and 0.03, respectively. All authors, except two 30,32 used color Doppler imaging to diagnose accreta placentation, and 5 authors 25, 27, 34, 36, 37 used magnetic resonance imaging as an aid to the ultrasound diagnosis. Transvaginal ultrasound was reported to be used by 6 authors, 25, 29, 30, 32, 37, 38 and 1 author reported on the use of translabial ultrasound.
36 Table 2 presents the secondary outcome characteristics of the 14 studies. Overall, there was 1 maternal death and no neonatal mortality. In 10 studies for which detailed data on the management of placenta previa accreta at delivery were available, 208 of 232 cases (89.7%) had an elective or emergent cesarean hysterectomy. Conservative management was attempted in 7 cases, including in 4 cases of focal myometrial resection of the accreta area. In 5 of these cases, the attempts to control the bleeding failed, and the total number of secondary hysterectomy (ie, performed as a second procedure after delivery) was 22.
Only 1 small retrospective study has reported data on the depth of accreta placentation. 26 Five retrospective studies and 1 prospective study (without outcome data) 36 were not included in the secondary analysis. The pooling of data of the remaining studies included 84 placenta creta, 53 placenta increta, and 37 placenta percreta.
Two studies 31, 38 provided detailed data on the relationship between the depth of villous invasion and the number of previous cesarean deliveries with the following distribution: 5 placenta creta, 1 placenta increta, and 2 placenta percreta after 1 cesarean delivery; 7 placenta creta, 7 placenta increta, and 11 placenta percreta after 2 cesarean deliveries; and 6 placenta creta, 3 placenta increta, and 8 placenta percreta after more than 2 cesarean deliveries.
Positive correlations were found in the largest prospective studies [30] [31] [32] 34, 35, 37, 38 between the cumulative rates of the more invasive forms of accreta placentation and the sensitivity ( 
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We found no data on the role of ultrasound in the screening of placenta accreta at the routine midtrimester ultrasound examination by non-expert operators.
Comment
Principal findings of the study This is the first systematic review in which the inclusion criteria are restricted to women presenting in the second trimester with a low anterior placenta/ placenta previa and a prior cesarean delivery and the first to evaluate the relationship between the depth of placental invasion, outcome, and management.
Our results show that the accuracy of both gray-scale and color Doppler ultrasound imaging in diagnosing placenta previa accreta in the second trimester in women presenting with a low placenta or placenta previa with 1 or more previous cesarean delivery is high when performed by expert operators. Data on the relationship between the depth of villous invasion are limited, and cesarean hysterectomy is the most common management approach for placenta previa accreta when diagnosed prenatally. Conservative management failed to prevent a secondary hysterectomy in the majority of attempted cases.
Comparison with existing literature
Overall, we found a 3.2-fold increase in the risk of placenta accreta after more than 1 cesarean delivery in women presenting with placenta previa, confirming the data of previous epidemiological studies. 11, 16, 39, 40 With the continuing increase in the number of cesarean deliveries, it is likely that the prevalence of placenta accreta will increase in the general population. Women with a previous history of cesarean delivery, presenting with a low-placenta or placenta previa in the second trimester of pregnancy, have become the largest group of women at the highest risk of placenta accreta.
We found a pooled sensitivity of 88% (95% CI, 81e93) and 97% (95% CI, 93-99) in retrospective and prospective studies, respectively. Ultrasound imaging techniques used for the prenatal diagnosis of placenta accreta have included gray-scale imaging, color Doppler imaging, and 3-dimensional ultrasound. Ultrasound machines equipped with color Doppler imaging and 3-dimensional ultrasound are less widely available than gray-scale imaging machines and require more skills and experience.
The results of well-conducted prospected cohort studies by Finberg et al 30 and Comstock et al 32 have indicated that the sensitivity and specificity of grayscale imaging alone in diagnosing for placenta previa accreta are high when performed by experienced operators. Finberg et al 30 reported a sensitivity for gray-scale imaging alone of 93% (95% CI, 68e100) and Comstock et al 32 reported an overall sensitivity of gray-scale ultrasound diagnostic criteria of 86%. This is contrast with the data from recent population studies reporting prenatal detection rates for placenta accreta as low as 29% including in women with prior cesarean delivery and Jauniaux. Prenatal diagnosis of placenta previa accreta after cesarean delivery. Am J Obstet Gynecol 2017.
ajog.org Systematic Reviews diagnosed prenatally with placenta previa. 13 These data suggest that color Doppler imaging and 3-dimensional ultrasound are not essential to the screening of accreta placentation.
In the prospective cohort studies included in the present review, the pooled accuracy of ultrasound imaging was higher in women presenting with a placenta previa or low-lying placenta than those reported in a previous general systematic review on the prenatal diagnosis of placenta accreta by ultrasound. 24 The present systematic review is different because we included only women with placenta previa and 1 or more prior cesarean deliveries.
In all the subsequent cohort studies on the prenatal diagnosis of placenta accreta, except one, 38 the authors also included women with a previous history of other uterine surgery, mainly myomectomy, curettage, and manual delivery of the placenta. Inclusion of women with previous uterine surgery other than a cesarean delivery is likely to weaken the accuracy of prenatal ultrasound diagnosis in women at risk of placenta accreta because the scar area can be anywhere in the uterine cavity and likely to be smaller and more superficial than that of a cesarean delivery scar.
Clinical implications
Accurate prenatal diagnosis is essential for women with placenta previa accreta because access to the fetus during cesarean delivery is often an issue due to the anterior position of the placenta. In cases of false-negative prenatal diagnosis, accreta placentation may not be detected by the surgeon during delivery, and a routine low transverse uterine incision will lead to major placental blood loss, even before the fetus is delivered.
By contrast, a false-positive diagnosis of accreta placentation will lead to an unnecessary midline vertical skin incision and a fundal uterine incision increasing the risks of intraoperative and postoperative complications and the risks of placenta accreta and uterine rupture in subsequent pregnancies.
Regionalization of care for women in centers of excellence by a multidisciplinary team requires accurate prenatal diagnosis of placenta previa accreta. [5] [6] [7] [8] [9] [10] Prenatal evaluation of the depth of placental invasion can also be useful for planning of individual management of women diagnosed with accreta placentation. 41 In particular, determining the degree of accreta invasion before delivery is essential to consent procedure, deciding on the optimal gestational age for delivery, and planning the corresponding multidisciplinary team expertise for delivery.
In a recent systematic review, we found that no single ultrasound sign or a combination of ultrasound signs were specific of the depth of accreta placentation but that some signs like placental lacunae and bulge and a focal placental exophytic mass were more often associated with deeper invasion of the myometrium. 42 In the present review, 8 of the 9 prospective studies provided detailed information on the depth of invasion and ultrasound findings but not Sensitivity and specificity of ultrasonography in invasive placentation in retrospective studies Forest plots of overall sensitivity and specificity of ultrasonography in the prenatal diagnosis of invasive placentation according to the current analysis in retrospective studies. Only the first author's name is given for each reference.
CI, confidence interval; OR, odds ratio.
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on the relationship between the grade of accreta placentation and the outcome.
In the cases included in 7 prospective cohorts, we found positive correlations between the cumulative rates of the more invasive forms of accreta placentation and sensitivity (P ¼ .39) and specificity (P ¼.29) of ultrasound imaging. There is a need for more prospective data on the accuracy of ultrasound imaging in determining the depth of villous invasion in women diagnosed with placenta previa accreta and its impact on clinical outcome.
Thurn et al 13 have recently indicated that hysterectomies were performed more often in the management of placenta accreta when the diagnosis is made prenatally than at delivery. The present review indicates that almost 90% of women diagnosed prenatally with placenta previa accreta have an elective or emergent cesarean hysterectomy.
Emergency peripartum hysterectomy is associated with considerable morbidity and mortality, and the risks are directly related to a previous cesarean delivery. 43 Recent data from the Perspective database on the risks of peripartum hysterectomy based on placenta previa and prior cesarean delivery delivered in the United States between 2006 and 2014 have indicated that high-risk cases are being increasingly referred to a tertiary care hospital. 44 These data also highlight the potential benefits of prenatal screening and diagnosis of placenta previa accreta on clinical outcome.
The data of the present review underscore the pivotal role of prenatal ultrasound diagnosis in optimizing the counseling, management, and outcome of individual women with placenta previa accreta. Ultrasound screening and diagnosis of placenta accreta is not routinely taught during ultrasound training courses in the United Kingdom. 45 Introducing such a screening program has been discussed but never implemented. 46 However, such ultrasound training and screening programs have existed for more than 2 decades for the detections of fetal anomalies such as congenital heart defect. 47, 48 In countries in which such a program exists, women at high risk of specific fetal abnormalities and those presenting with ultrasound markers suspicious of a congenital cardiac defect are referred to a specialist ultrasound unit for an expert review.
FIGURE 4
Sensitivity and specificity of ultrasonography in invasive placentation in prospective studies
Forest plots of overall sensitivity and specificity of ultrasonography in the prenatal diagnosis of invasive placentation according to the current analysis in prospective studies. Only first author's name is given for each reference.
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Considering the increased incidence of placenta previa accreta in women with prior cesarean delivery and the high maternal morbidity and mortality at delivery of undiagnosed cases, similar international screening protocols with standard anatomical views should be developed. These obstetric risk factors of accreta placentation should be identified and integrated into the clinical assessment at the first antenatal visit and at the midgestation routine ultrasound screening for fetal anomalies to improve the detection rate of placenta previa accreta during the second trimester of pregnancy.
Strengths and weaknesses
The main strengths of this review are the comprehensive search strategy, the identification of cases of placenta previa accreta in cohort studies on prenatal imaging, and specific inclusion criteria (exclusion of cases with no history of cesarean delivery). We have also correlated ultrasound features of accreta placentation with obstetric outcomes, highlighting the impact of prenatal diagnosis on management and emphasized the use of the corresponding ultrasound signs in screening women at high risks during the second trimester of pregnancy.
The main limitations of this review are the publications bias of retrospective studies on the accuracy of ultrasound diagnosis, the heterogeneity of some of the studies in the diagnosis of placenta previa, and variability in gestational age at diagnosis. Unlike magnetic resonance imaging, ultrasound examination is operator dependent, and thus, singlecenter studies often overestimate the accuracy of ultrasound because they are conducted by skilled operators in specialized centers and the overall numbers of cases of placenta accreta diagnosed prenatally in some cohorts are small.
The ultrasound definition of placenta previa initially included all types of abnormally low placentation (ie, with the placenta edge inside the lower uterine segment). Placenta previa were then graded according to their relationship and/or the distance between the placental edge and the internal os of the uterine cervix. 49 The use of transvaginal ultrasound has allowed for a more accurate evaluation of the relationship between the placental edge and the internal os, and it has been recently recommended to use the term, placenta previa, only for those placenta overlying the internal os and to refer to the others as low lying. 50 Several authors in our review have included both low-lying and placenta previa in their cohort, 25, 26, 29, 32, 37 do not report on the use of transvaginal ultrasound in the evaluation, [26] [27] [28] 31, 34 and/or have used different terminology to describe the position of the placenta inside the lower uterine segment. The diagnosis of placenta praevia is overestimated in pregnancies at less than 16 weeks of gestation, and 90% of the low-lying placenta diagnosed at the midgestation scan resolved before the term. [49] [50] [51] [52] [53] This can explain the wide range (0.7e47.2%) in the incidence of placenta previa accreta reported in the cohort studies included in this review. CSHT, cesarean hysterectomy; GA, gestational age; FMR, focal myometrial resection; second HT, secondary hysterectomy; N/A, not available; PC, placenta creta; PI, placenta increta; PP, placenta percreta.
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Conclusions The sensitivity and specificity of ultrasound imaging in diagnosing placenta previa accreta in women with a prior cesarean delivery, presenting with anterior low placenta or placenta previa, are >95% in prospective series when performed by skilled operators. Women with a history of a previous cesarean delivery, presenting with a placenta previa, have become the largest group with the highest risk of placenta previa accreta. These specific obstetric risk factors of accreta placentation should be identified and integrated into the general clinical assessment at the first antenatal visit and at the routine midgestation ultrasound examination to further improve the detection rate of placenta previa accreta during the second trimester of pregnancy.
Developing protocols for the screening of placenta previa accreta in women with prior cesarean delivery presenting with a low-lying or a placenta previa has become essential to improve the outcome of this increasingly more common major obstetric complication at national and international levels. Skills and expertise in identifying the main ultrasound signs of accreta placentation should be included in the general training of sonographers who are performing the routine midtrimester detailed fetal anatomy ultrasound examination.
